Down‐regulation of CYTL1 attenuates bleomycin‐induced pulmonary fibrosis in mice by inhibiting M2 macrophage polarization via the TGF‐β/CCN2 axis

Abstract

Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease characterized by chronic inflammation, lung tissue fibrotic changes and impaired lung function. Pulmonary fibrosis 's pathological process is thought to be influenced by macrophage‐associated phenotypes. IPF treatment requires specific targets that target macrophage polarization. Cytokine‐like 1(CYTL1) is a secreted protein with multiple biological functions first discovered in CD34+ haematopoietic cells. However, its possible effects on IPF progression remain unclear. This study investigated the role of CYTL1 in IPF progression in a bleomycin‐induced lung injury and fibrosis model. In bleomycin‐induced mice, CYTL1 is highly expressed. Moreover, CYTL1 ablation alleviates lung injury and fibrosis in vivo. Further, downregulating CYTL1 reduces macrophage M2 polarization. Mechanically, CYTL1 regulates transforming growth factor β (TGF‐β)/connective tissue growth factor (CCN2) axis and inhibition of TGF‐β pathway alleviates bleomycin‐induced lung injury and fibrosis. In conclusion, highly expressed CYTL1 inhibits macrophage M2 polarization by regulating TGF‐β/CCN2 expression, alleviating bleomycin‐induced lung injury and fibrosis. CYTL1 could, therefore, serve as a promising IPF target.